Caption: Pluristem Therapeutics Inc. (PSTI.TA) (PSTI.TA), a leading developer of placenta-based cell therapy products, announced today that it has been issued Patent No. 2013/07160, titled "Methods and Systems for Harvesting Adherent Stromal Cells",
Credit: Pluristem Therapeutics